|
1
|
Palomino MZ, Caicedo-Holguín I, Pardo S, Mera AT, Gómez AP and Zorrilla JO: Case report: Tumor collision in the colon, adenocarcinoma-lymphoma. Int J Surg Case Rep. 98:1075732022. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Montealegre RA and Barrera JC: Combined mohs micrographic surgery in a collision tumor. Cureus. 14:e267472022.PubMed/NCBI
|
|
3
|
Choe AR, Shim KN, Lim J, Song EM, Tae CH, Jung SA and Jo MS: A collision tumor of the esophagus: Mixed squamous cell carcinoma and neuroendocrine carcinoma. Korean J Gastroenterol. 75:207–211. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yılmaz DB, Bayramoğlu Z, Ünay G, Ayık E, Başsorgun Cİ and Elpek GÖ: Incidental collision tumor of hepatocellular carcinoma and neuroendocrine carcinoma. J Clin Transl Hepatol. 6:339–344. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jeng KS, Huang CC, Chung CS and Chang CF: Liver collision tumor of primary hepatocellular carcinoma and neuroendocrine carcinoma: A rare case report. World J Clin Cases. 10:13129–13137. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Choi GH, Ann SY, Lee SI, Kim SB and Song IH: Collision tumor of hepatocellular carcinoma and neuroendocrine carcinoma involving the liver: Case report and review of the literature. World J Gastroenterol. 22:9229–9234. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nishino H, Hatano E, Seo S, Shibuya S, Anazawa T, Iida T, Masui T, Taura K, Haga H and Uemoto S: Histological features of mixed neuroendocrine carcinoma and hepatocellular carcinoma in the liver: A case report and literature review. Clin J Gastroenterol. 9:272–279. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nakano A, Hirabayashi K, Yamamuro H, Mashiko T, Masuoka Y, Yamamoto S, Ozawa S and Nakagohri T: Combined primary hepatic neuroendocrine carcinoma and hepatocellular carcinoma: Case report and literature review. World J Surg Oncol. 19:782021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Garcia MT, Bejarano PA, Yssa M, Buitrago E and Livingstone A: Tumor of the liver (hepatocellular and high grade neuroendocrine carcinoma): A case report and review of the literature. Virchows Arch. 449:376–381. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ge XW, Zeng HY, Su-Jie A, Du M, Ji Y, Tan YS, Hou YY and Xu JF: Hepatocellular carcinoma with concomitant hepatic angiomyolipoma and cavernous hemangioma in one patient. World J Gastroenterol. 21:3414–3419. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Noh BG, Seo HI, Park YM, Kim S, Hong SB and Lee SJ: Complete resection of large-cell neuroendocrine and hepatocellular carcinoma of the liver: A case report. World J Clin Cases. 10:8277–8283. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gao YX, Ning QQ, Yang PX, Guan YY, Liu PX, Liu ML, Qiao LX, Guo XH, Yang TW and Chen DX: Recent advances in recurrent hepatocellular carcinoma therapy. World J Hepatol. 15:460–476. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lazzaro A and Hartshorn KL: A comprehensive narrative review on the history, current landscape, and future directions of hepatocellular carcinoma (HCC) systemic therapy. Cancers (Basel). 15:25062023. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fischer AK, Beckurts KTE, Büttner R and Drebber U: Giant cavernous hemangioma of the liver with satellite nodules: Aspects on tumour/tissue interface: A case report. World J Hepatol. 15:707–714. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kanda T, Goto T, Hirotsu Y, Moriyama M and Omata M: Molecular mechanisms driving progression of liver cirrhosis towards hepatocellular carcinoma in chronic hepatitis b and c infections: A Review. Int J Mol Sci. 20:13582019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Russo FP, Zanetto A, Pinto E, Battistella S, Penzo B, Burra P and Farinati F: Hepatocellular carcinoma in chronic viral hepatitis: Where do we stand? Int J Mol Sci. 23:5002022. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang C and Cui F: Expanded screening for chronic hepatitis B virus infection in China. Lancet Glob Health. 10:e171–e172. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang J, Qi JL, Wang XX, Li XH, Jin R, Liu BY, Liu HX and Rao HY: The burden of hepatitis C virus in the world, China, India, and the United States from 1990 to 2019. Front Public Health. 11:10412012023. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tamaoka K, Tanemura M, Furukawa K, Mikamori M, Saito T, Ohtsuka M, Suzuki Y, Tei M, Kishi K, Yasuoka H, et al: Primary intrahepatic squamous cell carcinoma with histological collision of adenocarcinoma and squamous cell carcinoma: A case report. Am J Case Rep. 19:1184–1191. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim E and Viatour P: Hepatocellular carcinoma: Old friends and new tricks. Exp Mol Med. 52:1898–1907. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hu S, Lyu X, Li W, Cui X, Liu Q, Xu X, Wang J, Chen L, Zhang X and Yin Y: Radiomics analysis on noncontrast CT for distinguishing hepatic hemangioma (HH) and hepatocellular carcinoma (HCC). Contrast Media Mol Imaging. 2022:76936312022. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhu HD, Li HL, Huang MS, Yang WZ, Yin GW, Zhong BY, Sun JH, Jin ZC, Chen JJ, Ge NJ, et al: CHANCE001 Investigators: Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001). Signal Transduct Target Ther. 8:582023. View Article : Google Scholar : PubMed/NCBI
|
